Oxcarbazepine
From Anvita Health Wiki
Contents |
Indications
- partial seizures ( FDA approved use)
- trigeminal neuralgia
- mania
Dosage
Pharmacokinetics
- metabolized in liver to 10-Hydroxycarbazepine
Monitor
- thyroid functions tests periodically
- serum Na+ [4]
- hyponatremia generally occurs within 1st 3 months of therapy
- consider routine periodic monitoring
- monitor with fluid retention or dyspnea in heart failure
- monitor with renal insufficiency associated with low serum Na+ at baseline: check in 2 weeks & monthly for 3 months
- as clinically indicated
Adverse-effects
- less likely than carbamazepine to cause serious hematologic toxicity or severe skin reactions
- other adverse effects similar to carbamazepine
Drug-interactions
- other anti-epileptic agents
- may reduce efficacy of oral contraceptives
- oxcarbazepine induces cyt P450 3A4
- may diminish levels of drugs metabolized by cyt P450 3A4
More General Terms
Additional Terms
Internet Database
PubChem: 34312
References
- Prescriber's Letter 7(2):7, Feb. 2000
- Kaiser Permanente Northern California Regional Drug Formulary, 2000
- FDA Medwatch [1]
- Prescriber's Letter 17(7): 2010 Recommended Lab Monitoring for Common Medications Detail-Document#: [2] (subscription needed) [3]
- Greiner-Sosanko E et al Drug monitoring: simultaneous analysis of lamotrigine, oxcarbazepine, 10-hydroxycarbazepine, and zonisamide by HPLC-UV and a rapid GC method using a nitrogen-phosphorus detector for levetiracetam J Chromatogr Sci. 2007 October; 45(9): 616-622 [4]
